Cahill Brian Joseph 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
Cahill Brian Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-27+3,800→ 49,547 total - Tax Payment
Common Stock
2024-02-27$6.44/sh−1,589$10,233→ 47,958 total
Footnotes (2)
- [F1]Represents common stock issued upon satisfaction of certain performance criteria contained in performance stock units ("PSUs") granted in 2021.
- [F2]The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of the PSUs and does not represent a discretionary transaction by the Reporting Person.